Bryn advances anaphylaxis nasal spray after completing pivotal trial

Bryn Pharma is advancing its nasal spray challenger to EpiPen autoinjectors. Having wrapped up a pivotal study that pitted the two rivals against each other, the North Carolina-based drug developer is moving forward through the regulatory process.